K253422 · Cognition Medical Corp. · QJP · Oct 2, 2026 · Cardiovascular
Device Facts
Record ID
K253422
Device Name
OAB Delivery Catheter
Applicant
Cognition Medical Corp.
Product Code
QJP · Cardiovascular
Decision Date
Oct 2, 2026
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 870.1250
Device Class
Class 2
Indications for Use
The OAB Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the neurovasculature.
Device Story
Variable stiffness, single-lumen catheter; reinforced with metal braid, coil, and polymer layers; features tapered tip with radiopaque markers and distal hydrophilic coating. Used in neurovascular procedures; inserted into compatible access catheter; advanced over neurovascular guidewire under fluoroscopic guidance. Enables infusion of diagnostic agents and delivery of interventional devices. Operated by physicians in clinical settings. Provides mechanical pathway for interventional tools; facilitates navigation through complex vasculature; enhances procedural efficiency.
Clinical Evidence
No clinical data. Substantial equivalence supported by extensive bench performance testing, including dimensional verification, air/liquid leak, bond strength, flow rate, tip flexibility, torque strength, static burst, corrosion, hub compatibility, particulate generation, simulated use, kink resistance, coating integrity/lubricity, and radiopacity. Biocompatibility testing performed per ISO 10993-1 (cytotoxicity, sensitization, irritation, pyrogenicity, acute systemic toxicity, and hemocompatibility).
Technological Characteristics
Single-lumen catheter; metal braid/coil/polymer construction; hydrophilic coating (66 cm). Dimensions: 0.021" ID; 0.062"-0.070" OD. Sterilized via Ethylene Oxide (ISO 11135). Hubs compliant with ISO 80369-7/20. Mechanical sensing/actuation via manual manipulation under fluoroscopy.
Indications for Use
Indicated for patients requiring intravascular infusion of diagnostic agents (e.g., contrast media) or delivery of interventional devices (e.g., distal access catheters) within peripheral, coronary, and neurovasculature.
Regulatory Classification
Identification
A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.
{1}
**FDA** U.S. FOOD & DRUG
ADMINISTRATION
October 2, 2026
Cognition Medical Corp.
% Robert Herrmann, Ph.D.
Director, Neurointerventional Regulatory Affairs
MCRA, LLC
803 7th Street, NW, 3rd Floor
Washington, DC 20001
Re: K253422
Trade/Device Name: OAB Delivery Catheter
Regulation Number: 21 CFR 870.1250
Regulation Name: Percutaneous Catheter
Regulatory Class: Class II
Product Code: QJP, DQY
Dated: September 1, 2026
Received: September 1, 2026
Dear Robert Herrmann:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov
{2}
K253422 - Robert Herrmann, Ph.D.
Page 2
Before making any change significantly affecting the safety or effectiveness of the device, you must submit a new premarket notification in accordance with 21 CFR 807.81. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the
{3}
K253422 - Robert Herrmann, Ph.D.
Page 3
Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
NAIRA MURADYAN -S
Naira Muradyan, PhD
Assistant Director
DHT5A: Division of Neurosurgical,
Neurointerventional, and
Neurodiagnostic Devices
OHT5: Office of Neurological and
Physical Medicine Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
{4}
| Indications for Use | | |
| --- | --- | --- |
| Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | K253422 | ? |
| Please provide the device trade name(s). | | ? |
| OAB Delivery Catheter | | |
| Please provide your Indications for Use below. | | ? |
| The OAB Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the neurovasculature. | | |
| Please select the types of uses. | ☑ Prescription Use (21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | ? |
{5}
K253422
COGNITION MEDICAL
Page 1 of 7
# 510(k) SUMMARY
# Submitter's Name and Address, Contact Person and Date Prepared
Cognition Medical Corporation
103 Calibre Woods Dr NE
Atlanta, GA 30329
Phone: (617) 682-6019
Email: alex@cognitionmedical.com
Contact: Alex Turjman
Phone: (617) 682-6019
Email: alex@cognitionmedical.com
Date Prepared: September 30, 2026
# 1. Device Name and Classification
Trade name: OAB Delivery Catheter
Common name: Percutaneous Catheter
Regulation: 21 CFR 870.1250 - Percutaneous Catheter
Regulatory class: II
Product code: QJP, DQY
# 2. Predicate Device
Submission Number: K230609
Trade name: NG Delivery Catheter
Regulation: 21 CFR 870.1250 – Percutaneous Catheter
Regulatory class: II
Product code: QJP, DQY
# 3. Reference Device
Submission Number: K172014
Trade name: Wedge Microcatheter
Regulation: 21 CFR 870.1250 – Percutaneous Catheter
Regulatory class: II
Product code: DQY
# 4. Device Description
The OAB Delivery Catheter is a variable stiffness single lumen catheter reinforced with metal braid, coil and polymer layers, with a tapered tip delineated by radiopaque markers. The distal shaft of the OAB Delivery Catheter has a hydrophilic coating. The device is provided sterile and non-pyrogenic and is intended for single use only. During use, a neurovascular guidewire may be inserted into the OAB Delivery Catheter. The OAB Delivery Catheter is inserted into a compatible access catheter. The OAB Delivery Catheter and access catheter are advanced to the targeted location under fluoroscopy using common endovascular techniques. The lumen of the catheter extends from the proximal luer port to the distal tip with a minimum inner diameter (ID) of 0.021" and a maximum outer diameter (OD) of 0.070" for the larger version and 0.062" for the smaller version.
{6}
K253422
COGNITION MEDICAL
Page 2 of 7
##### 5. Indications for Use
The OAB Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the neurovasculature.
##### 6. Comparison of Technological Characteristics with the Predicate Device
The subject and predicate devices have similar dimensions and principles of operation. Both subject and predicate devices have a hydrophilic coating, and both use similar packaging systems.
| Attribute | Predicate Device: NG Delivery Catheter (K230609) | Reference Device: Wedge Microcatheter (K172014) | Subject Device: OAB Delivery Catheter (K253422) |
| --- | --- | --- | --- |
| Classification | Class II | Class II | Class II |
| Product Code | QJP, DQY | DQY | QJP, DQY |
| Manufacturer | Balt USA, LLC | MicroVention, Inc. | Cognition Medical Corp. |
| Intended Use / Indications for Use | The NG Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the | The Wedge Microcatheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as the | The OAB Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the |
{7}
K253422
COGNITION MEDICAL
Page 3 of 7
| | neurovasculature. | SOFIA 6F Catheter, in the neurovasculature. | neurovasculature. |
| --- | --- | --- | --- |
| Working Lengths | 152 cm | 158-160 cm | 154 cm |
| Distal Tip Configuration | Tapered Tip | Bulb with extension | Tapered tip Tapered tip with extension |
| Sterilization Method | Ethylene Oxide | Ethylene Oxide | Same |
| Single Use Device | Yes | Yes | Same |
| Catheter ID | 0.021” | 0.021” | Same |
| Catheter OD, Max | 0.059” (1.50 mm) – 0.069” (1.75 mm) | 0.028” - 0.034” (0.71-0.86 mm) 0.068” (1.73 mm) for bulb feature (~1 cm) | 0.062” (1.63 mm) – 0.070” (1.83 mm) |
| Coating | Distal hydrophilic coating (60 cm) | Distal hydrophilic coating (110-115 cm) | Distal hydrophilic coating (66 cm) |
| Packaging Configuration | Microcatheter is placed in a dispenser hoop and accessories on a mounting card that is then inserted into the pouch. The pouch is then placed inside a carton box. | Microcatheter is placed in a dispenser hoop and accessories on a mounting card that is then inserted into the pouch. The pouch is then placed inside a carton box. | The OAB Delivery Catheter is placed in a dispenser hoop that is then inserted into a pouch. The pouch is then placed inside a carton box. |
### 7. Testing
The OAB Delivery Catheter was evaluated using the following non-clinical testing.
Performance Testing – Bench
The following bench performance testing was performed to demonstrate the OAB Delivery Catheter performs as intended.
| Test | Description | Results |
| --- | --- | --- |
| Dimensional Verification | This test verified the dimensional specifications. | Pass – all samples met the pre-determined acceptance criteria. |
{8}
K253422
COGNITION MEDICAL
Page 4 of 7
| Visual Inspection | This test verified that the visual surface requirements were met. | Pass – all samples met the pre-determined acceptance criteria. |
| --- | --- | --- |
| Air Leak | The catheter was tested according to ISO 10555-1, Annex I. | Pass – all samples met the pre-determined acceptance criteria. |
| Liquid Leak | The catheter was tested according to ISO 10555-1, Annex C. | Pass – all samples met the pre-determined acceptance criteria. |
| Catheter Bond Strength | The catheter was evaluated to verify the peak bond strength meets specifications. | Pass – all samples met the pre-determined acceptance criteria. |
| Flow Rate | The flow rate through the catheter was measured per ISO 10555-1 Annex E and compared to the reference device. | Pass – all samples met the pre-determined acceptance criteria. |
| Tip Flexibility | The flexibility of the catheter tip was verified. The catheter stiffness profile was compared to the predicate device. | Pass – all samples met the pre-determined acceptance criteria. |
| Torque Strength | The catheter was evaluated for torque strength by rotating the test samples in an anatomical model with the distal tip fixed and recording the number of rotations to failure. | Pass – all samples met the pre-determined acceptance criteria. |
| Static Burst | The catheter was tested according to ISO 10555-1, Annex F. | Pass – all samples met the pre-determined acceptance criteria. |
| Corrosion | The catheter was tested according to ISO 10555-1, Annex A. | Pass – all samples met the pre-determined acceptance criteria. |
| Hub Compatibility | The hub was tested according to ISO 80369-7 and ISO 80369-20. | Pass – all samples met the pre-determined acceptance criteria. |
| Particulate | The catheter was evaluated for particulate generation during simulated use in an anatomical model and compared to predicate and reference devices. | Pass – all samples met the pre-determined acceptance criteria. |
| Simulated Use | The catheter was evaluated in a simulated anatomical model for ease of preparation, accessory device compatibility, trackability, lubricity and kink resistance. | Pass – all samples met the pre-determined acceptance criteria. |
| Kink Resistance | The catheter was evaluated for resistance to kinking around bends with clinically relevant radii. | Pass – all samples met the pre-determined acceptance criteria. |
{9}
K253422
COGNITION MEDICAL
Page 5 of 7
| Coating Integrity | The catheter was evaluated for coating integrity and coverage. | Pass – all samples met the pre-determined acceptance criteria. |
| --- | --- | --- |
| Coating Lubricity and Durability | The catheter was evaluated for frictional forces and coating durability. | Pass – all samples met the pre-determined acceptance criteria. |
| Radiopacity | The catheter was visualized under fluoroscopy to demonstrate equivalence with predicate in terms of radiopacity. | Pass – all samples met the pre-determined acceptance criteria. |
### Biocompatibility testing
Biocompatibility testing was conducted according to FDA Guidance “Use of International Standard ISO 10993-1, “Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process”.” The tests performed are listed below.
| Test | Test Summary | Conclusions |
| --- | --- | --- |
| Cytotoxicity – MEM Elution Test | The device was evaluated for potential cytotoxic effects following ISO 10993-5 guidelines. | Non-cytotoxic |
| Sensitization – ISO Guinea Pig Maximization Sensitization | The device was evaluated for the potential to cause sensitization in guinea pigs based on ISO 10993-10. The test animals showed no evidence of inducing sensitization. | Non-sensitizing |
| Irritation – Intracutaneous Reactivity | The device was evaluated for the potential to cause irritation following intracutaneous injection in rabbits based on ISO 10993-23. The extracts of the test article show no evidence of irritation. | Non-irritant |
| Pyrogenicity – Material Mediated Pyrogenicity Test | The device was evaluated for the potential to induce a pyrogenic response following intravenous injection in rabbits based on ISO 10993-11. The total rise of temperature was within the acceptable range. | Non-pyrogenic |
| Acute Systemic Toxicity | The device was evaluated for acute systemic toxicity in mice based on ISO 10993-11. No change was observed in general conditions or in necropsy. | No systemic toxicity |
{10}
K253422
COGNITION MEDICAL
Page 6 of 7
| Hemocompatibility - Hemolysis Testing (direct and indirect) | The device was evaluated for hemolytic potential when in contact with blood based on ISO 10993-4 and ASTM F756 standard. | The test article is non-hemolytic. |
| --- | --- | --- |
| Hemocompatibility – Complement Activation | The SC5b-9 assay was conducted to assess complement activation. | The test article is considered a non-activator of the complement system. |
| Hemocompatibility – Thrombogenicity | Thrombogenicity was assessed using an in vitro blood flow loop based on ISO 10993-4. | The test article is thromboresistant. |
| Hemocompatibility – Platelet Leukocyte Count | Platelet and leukocyte count testing was performed according to ASTM F2888 and ISO 10993-4. | Test device is hemocompatible. |
| Hemocompatibility – Partial Thromboplastin Time (PTT) | PTT test performed according to ASTM F2382. | Test device does not activate the coagulation cascade. |
#### Sterilization, Packaging and Shelf Life
The OAB Delivery Catheter is sterilized using ethylene oxide. The sterilization cycle was validated to ensure a sterility assurance level (SAL) of \( 10^{-6} \) in accordance with ISO 11135.
The OAB Delivery Catheter packaging consists of a protective hoop and pouch. Packaging validation studies were conducted to demonstrate the packaging system provides adequate protection of the device and sterility through the product life cycle.
Aging studies for the device have been conducted and demonstrated a 2-year shelf life. Testing demonstrated adequate packaging and device performance.
#### Animal Testing
Animal testing was not deemed necessary to demonstrate substantial equivalence.
#### Clinical Testing
Clinical testing was deemed to be not necessary to demonstrate substantial equivalence.
## 8. Conclusions
{11}
K253422
COGNITION MEDICAL
Page 7 of 7
The OAB Delivery Catheter and the predicate NG Delivery Catheter (K230609) have similar intended use, device operating principle, technological characteristics and indications for use. The differences in technological characteristics do not raise new questions of safety or effectiveness. The non-clinical testing demonstrates that the subject OAB Delivery Catheter performs as intended and supports substantial equivalence to the predicate device.
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Guidance alerts
New and changed FDA guidance documents, emailed as a daily digest.
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the ? button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only Software as a Medical Device, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (Software as a Medical Device), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.